Allergen immunotherapy: A practice parameter third update

Task force reportAllergen immunotherapy: A practice parameter third updateChief Editors: Linda Cox, MD, Harold Nelson, MD, and Richard Lockey, MDWorkgroup Contributors: Christopher Calabria, MD, Thomas Chacko, MD, Ira Finegold, MD, Michael Nelson, MD, PhD,and Richard Weber, MDTask Force Reviewers: David I. Bernstein, MD, Joann Blessing-Moore, MD, David A. Khan, MD, David M. Lang, MD,Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher Randolph, MD, Diane E. Schuller, MD,Sheldon L. Spector, MD, Stephen Tilles, MD, and Dana Wallace, MDKeywords:Allergy immunotherapy, subcutaneous immunotherapy,sublingual immunotherapy, allergic rhinitis, asthma, Hymenoptera,atopic dermatitis, anaphylaxis, epinephrine,b-blockers, angioten-sin-converting enzyme inhibitor, epicutaneous immunotherapy, in-tralymphatic immunotherapy, nasal immunotherapyThese parameters were developed by the Joint Task Force onPractice Parameters, representing the American Academy ofAllergy, Asthma & Immunology (AAAAI); the American Col-lege of Allergy, Asthma & Immunology (ACAAI); and the JointCouncil of Allergy, Asthma & Immunology.

Yale University New Haven, Connecticut Diane E. Schuller, MD Department of Pediatrics Pennsylvania State University Milton S. Hershey Medical College Hershey, Pennsylvania Sheldon L. Spector, MD Department of Medicine UCLA School of Medicine Los Angeles, California Stephen A. Tilles, MD Department of Medicine University of Washington School of ...

Loading..

Tags:

  School, University, Medicine, Yale, Yale university, Of medicine, School of medicine, Of medicine university

Information